Showing results (221-230 of 636) with videos related to

Sort By:
Pageof 64
Nature Materials|March 5, 2025
Surfactant-induced hole concentration enhancement for highly efficient perovskite light-emitting diodesJiajun Qin, Jia Zhang, Xianjie Liu, et al.
Physical Review Letters|June 13, 2009
Superhard semiconducting optically transparent high pressure phase of boronE Yu Zarechnaya, L Dubrovinsky, N Dubrovinskaia, et al.
Nature|January 6, 2012
Differential oestrogen receptor binding is associated with clinical outcome in breast cancerCaryn S Ross-Innes, Rory Stark, Andrew E Teschendorff, et al.
Nucleic Acids Research|November 12, 2005
T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motifMarie J Lucey, Dongsheng Chen, Jorge Lopez-Garcia, et al.
Nucleic Acids Research|October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Molecular Cancer Therapeutics|March 17, 2018
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer TreatmentHetal Patel, Manikandan Periyasamy, Georgina P Sava, et al.
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast CancerWilbert Zwart, Koen D Flach, Bharath Rudraraju, et al.
British Journal of Cancer|April 19, 2023
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
Cell Death & Disease|March 17, 2017
Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutationsJoel Fulton, Bismoy Mazumder, Jonathan B Whitchurch, et al.
Pageof 64